The polymerase chain reaction (PCR) is
a widely used technology for DNA amplification. It produces hundreds of
thousands to millions of copies of a certain DNA sequence. The PCR industry is
turning its focus away from macro-scale systems and toward micro-scale device
development. Micro-scale devices provide a number of advantages, including the
fact that they require less blood from patients, take less time to react, and
are cost-effective because many microfluidic devices are made of low-cost
polymers. Over the forecast period, the market is expected to rise due to
rising acceptance of polymerase chain reaction in various diagnostic and
research applications, rising research and development spending in gene
therapy, and continuing technological innovation in polymerase chain reaction.
Increasing Numbers of Product Launches and
Collaborations in Polymerase Chain Reaction are expected to Drive Growth of the
Polymerase Chain Reaction Market
The polymerase chain reaction Polymerase
Chain Reaction
market's major
manufacturers are working to introduce advanced and unique PCR instruments and
consumables that would allow for rapid and simple nucleic acid amplification.
Diatech Pharmacogenetics srl, for example, introduced easyPGX, a ready-to-use
in-vitro diagnostic real-time PCR product line, and Helix, a polymerase chain
reaction kit for the extraction of circulating free DNA from plasma, in October
2017. Bio-Rad Laboratories released a droplet digital PCR Supermix for Residual
DNA Quantification in September 2015. The new supermix, which is designed to
work with Bio-Droplet Rad's Digital PCR Systems, provides a very exact and
sensitive DNA measurement approach. Chai Biotechnologies Inc. introduced Open
qPCR: Real-Time PCR Thermocycler in November 2014. The novel device will be
used for genetic genotyping, pathogen detection, and relative DNA quantification.
Increasing Prevalence of Chronic and
Infectious Disease are Driving Growth of Polymerase Chain Reaction Market
The polymerase
chain reaction market is being more widely utilised in infectious
illness clinical diagnosis, nucleic acid amplification, paternity testing, DNA
fingerprinting, infectious disease detection and diagnosis, quality control,
and customised medicine. According to the Centers for Disease Control and
Prevention (CDC), approximately 5,251 deaths in the United States were caused
by influenza infection in 2015. According to the World Health Organization
(WHO), over 32,000 estimated tuberculosis deaths and 3, 23,000 new tuberculosis
cases were recorded in the European region in 2015. In the United States, 16.8
million visits to physician offices for infectious and parasitic disorders were
recorded in 2015, according to the National Ambulatory Medical Care Survey:
2015 data findings. According to the World Health Organization (WHO), there
were around 555,318 new cancer cases recorded in the Middle East Region in
2012.
Comments
Post a Comment